Correlation Between Diffusion Pharmaceuticals and ABVC Biopharma
Can any of the company-specific risk be diversified away by investing in both Diffusion Pharmaceuticals and ABVC Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Diffusion Pharmaceuticals and ABVC Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Diffusion Pharmaceuticals and ABVC Biopharma, you can compare the effects of market volatilities on Diffusion Pharmaceuticals and ABVC Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Diffusion Pharmaceuticals with a short position of ABVC Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Diffusion Pharmaceuticals and ABVC Biopharma.
Diversification Opportunities for Diffusion Pharmaceuticals and ABVC Biopharma
0.65 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Diffusion and ABVC is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Diffusion Pharmaceuticals and ABVC Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABVC Biopharma and Diffusion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Diffusion Pharmaceuticals are associated (or correlated) with ABVC Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABVC Biopharma has no effect on the direction of Diffusion Pharmaceuticals i.e., Diffusion Pharmaceuticals and ABVC Biopharma go up and down completely randomly.
Pair Corralation between Diffusion Pharmaceuticals and ABVC Biopharma
Given the investment horizon of 90 days Diffusion Pharmaceuticals is expected to under-perform the ABVC Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Diffusion Pharmaceuticals is 2.48 times less risky than ABVC Biopharma. The stock trades about -0.11 of its potential returns per unit of risk. The ABVC Biopharma is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 746.00 in ABVC Biopharma on August 29, 2024 and sell it today you would lose (695.00) from holding ABVC Biopharma or give up 93.16% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 31.45% |
| Values | Daily Returns |
Diffusion Pharmaceuticals vs. ABVC Biopharma
Performance |
| Timeline |
| Diffusion Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| ABVC Biopharma |
Diffusion Pharmaceuticals and ABVC Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Diffusion Pharmaceuticals and ABVC Biopharma
The main advantage of trading using opposite Diffusion Pharmaceuticals and ABVC Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Diffusion Pharmaceuticals position performs unexpectedly, ABVC Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABVC Biopharma will offset losses from the drop in ABVC Biopharma's long position.| Diffusion Pharmaceuticals vs. Bio Path Holdings | Diffusion Pharmaceuticals vs. Capricor Therapeutics | Diffusion Pharmaceuticals vs. NextCure | Diffusion Pharmaceuticals vs. Tonix Pharmaceuticals Holding |
| ABVC Biopharma vs. Bright Minds Biosciences | ABVC Biopharma vs. HP Inc | ABVC Biopharma vs. Intel | ABVC Biopharma vs. Chevron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |